Blog

Phuong Ly-Gallagher: What can be done NOW in the global space to advance care in colorectal cancer

Photo from Phuong Ly-Gallagher/LinkedIn

Jun 11, 2024, 05:36

Phuong Ly-Gallagher: What can be done NOW in the global space to advance care in colorectal cancer

Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at

“’It is better represented in phase III studies but has almost negligible participation in other trial phases.’

As we approach Fight Colorectal Cancer’s next (virtual) Early Onset Think Tank, consider this in what can be done NOW in the global space to advance care in colorectal cancer.”

Quoting

“ASCO2024 LATAM Our analysis showed that the Latin American region is underrepresented in clinical trials. While 7.7% of all cancer cases in 2020 were diagnosed in LATAM, only 3.64% of oncology trials were conducted there. Scope for improvement!”

Read further.
Source: Phuong Ly-Gallagher/LinkedIn and Kamal S. Saini/LinkedIn

advancing cancer care ASCO24 cancer cancer diagnosis rates Cancer research clinical trial participation clinical trial representation colorectal cancer care Early Onset Think Tank Fight Colorectal Cancer Fortrea Inc. global oncology Kamal S. Saini Latin American region LATM OncoDaily Oncology oncology trial disparities oncology trials phase III studies Phuong Ly-Gallagher Research Research Advocate Training and Support (RATS) Manager

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage